Group 5A: HR+ Breast Cancer; Quality of Life; Older Populations

Poster #PO1-04-13: CARDIAC-STAR: Prevalence of cardiovascular comorbidities in hormone receptor positive human epidermal growth factor negative metaStatic breasT cAnceR.

Poster #PS02-01: Efficacy, safety, and quality of life with ribociclib + endocrine therapy in elderly patients with HR+/HER2– advanced breast cancer across the MONALEESA-2, -3, and -7 trials.